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Influenza is a major cause of mortality and morbidity. We aimed to examine the influenza-associated hospitalization rates and proportions for cardiovascular disease (CVD) in tropical Singapore. Hospital admissions for ischemic heart disease (IHD), congestive heart failure (CHF), and overall CVD were obtained from the national inpatient database for the period of 2010-2014. We used, as the key indicator of influenza virus activity, the overall proportion of specimens from outpatients with influenza-like illness in the community that tested positive for influenza as part of the national influenza surveillance program. The annual influenza-associated hospitalization rates per 100,000 personyears ranged from 9.5 to 12.2 for IHD, 7.7 to 9.1 for CHF, and 15.8 to 19.2 for overall CVD. The influenza-associated hospitalization rates increased with increasing age. Influenza was significantly associated with excess hospitalizations in elderly persons aged ≥80 years, with an excess hospitalization rate per 100,000 person-years of 242.7 for IHD (P = 0.02), 271.8 for CHF (P = 0.01), and 497.2 for overall CVD (P < 0.001). In the tropics, influenza accounts for excess cardiovascular-related hospitalizations, especially in the elderly.
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Influenza is a cause of major mortality and morbidity, with a large proportion of cases resulting in respiratory-tract illnesses (1) . Beyond respiratory manifestations, several studies have shown a likely association between influenza and cardiovascular disease (CVD). CVD encompasses a broad spectrum of disease entities, of which ischemic heart disease (IHD) and congestive heart failure (CHF) account for the vast majority of cases. The relationship between influenza and IHD could be linked to inflammation, while increasing metabolic demand during influenza infections could result in decompensated heart failure (2).
Influenza epidemics have been shown to result in an acute increase in IHD deaths confirmed by autopsy in Russia (3) . The association between the IHD mortality rate and influenza infection in winter peaks has also been documented in temperate regions (4) . A study in the United States found an increase in acute myocardial infarction hospitalizations in the elderly with influenza activity (5) . In subtropical Hong Kong, influenza was associated with IHD hospitalizations in persons aged ≥75 years but not in those in the age group 65-74 years (6) . Some studies found an increasing risk of CHF admissions associated with influenza (7, 8) , but Upshur et al. (9) found this link to be inconsistent.
The majority of the data used in existing studies have been from temperate countries with a single winter peak in influenza infections. In tropical Singapore, it has been shown that there is a continuous circulation of influenza viruses year-round, with bimodal peaks in influenza activity usually observed in the middle and at the end of the year (10) . Local studies on influenza-associated hospitalizations for pneumonia and influenza and the influenza-associated mortality rate have indicated the considerable role of influenza in health outcomes in Singapore (11) (12) (13) . We aimed to examine the influenza-associated hospitalization rates and proportions for CVD, focusing in particular on IHD and CHF, in Singapore.
METHODS

Data sources
Singapore is a developed city-state of 5.5 million people in tropical Southeast Asia. Hospital admission data from all hospitals in Singapore are comprehensively captured in the electronic national medical payment and claims system. For this study, we aggregated data from the system according to the week of admission. Discharge diagnoses were coded according to the International Classification of Diseases, Ninth Revision (ICD-9), before 2012 and the tenth revision (ICD-10) since 2012. We analyzed 3 disease groupings based on principal discharge diagnosis: IHD (ICD-9: 410-414; ICD-10 I20- 
Influenza virological surveillance
Through the national surveillance program for influenza (11) , which was enhanced after the influenza A(H1N1) pdm09 pandemic in 2009, nasopharyngeal and/or throat swab specimens are obtained from outpatients with influenza-like illness (ILI)-defined as temperature >38°C plus cough or sore throat-at sentinel government primary care clinics and private general practitioner clinics for influenza virus subtyping. Real-time reverse transcription polymerase chain reaction is used to determine influenza virus types and subtypes.
Statistical analysis
Five age groups were analyzed (<50 years, 50-64 years, 65-79 years, ≥80 years, and all ages). For each disease grouping and age group, we fitted the following negative binomial regression model to weekly numbers of hospitalization:
weekly number of hospitalizations week number influenza respiratory syncytial virus weekly mean temperature weekly mean relative humidity .
The weekly percentage of specimens positive for influenza across all ages comprised influenza A of all subtypes (H3N2, seasonal H1N1, and H1N1-pdm09) and influenza B, and this percentage was entered into the model to estimate influenza association. Because using the age-specific proportion of influenza-positive specimens would have resulted in too few specimens for statistical analysis from older outpatients (>65 years of age) consulting for ILI, the all-ages proportion was used instead. We adjusted for the activity of respiratory syncytial virus in the model by including the weekly percentage of specimens positive for respiratory syncytial virus from 2 public acute-care hospitals with departments of pediatrics, which cover 63%-68% of hospitalizations among children <15 years of age in Singapore (11) .
To capture long-term trend and seasonality, we used a natural cubic spline function (piecewise smoothing polynomials) for week number. We also used a nonlinear function with a natural cubic spline for weekly mean temperature and weekly mean relative humidity, which were included in the regression models as covariates. The number of degrees of freedom for each smoothing function was selected in a sequence to minimize the Akaike information criterion.
We evaluated validity for each model. Residuals were examined for discernible patterns and autocorrelation using residual plots and partial autocorrelation function plots, respectively. The specifications were found to be adequate, and there was no need to include autoregressive terms of residuals in the models.
Influenza-associated excess hospitalizations
We first computed the difference between the observed weekly number of hospitalizations and the expected weekly number of hospitalizations when the weekly proportion of specimens positive for influenza was set to zero in the model. Estimation of the annual number of excess hospitalizations was obtained as the sum of all positive weekly differences for each year (i.e., negative weekly differences were recoded to 0). We then estimated the proportion of influenza-associated hospitalizations by dividing the total number of excess hospitalizations by the total number of observed hospitalizations.
The 95% confidence interval for each estimated proportion was obtained by using the bootstrap resampling method with 1,000 resamples. The 2.5% and 97.5% quantiles of the 1,000 estimates were taken as the lower and upper bounds, respectively. The 95% confidence interval for the number of influenza-associated admissions was then derived by multiplying the number of observed admissions by the 95% confidence interval for the proportion of influenza-associated admissions. The annual influenza-associated hospitalization rate per 100,000 person-years was obtained by dividing the total number of excess admissions by the annual mid-year population estimate in the corresponding year. Statistical analyses were performed using R, version 3.1.3 (R Foundation for Statistical Computing, Vienna, Austria).
RESULTS
CVD hospitalizations
During 2010-2014, the mean annual numbers of hospitalizations in the all-ages group were 17,149 for IHD (range, 16, 466-17,854), 7,000 for CHF (range, 5,682-7715), and 26,280 for overall CVD (range, 24,323-27,814), respectively. Among the hospitalizations for overall CVD in the all-ages group during the 5-year study period, IHD and CHF constituted 65.3% and 26.6% of all hospitalizations, respectively. The hospitalization rates per 100,000 personyears for IHD, CHF, and overall CVD increased with increasing age, and were highest in those aged ≥80 years ( Table 1 ). The weekly numbers of hospitalizations for IHD, CHF, and overall CVD and the proportion of influenzapositive specimens from virological surveillance are shown in Figure 1 .
Influenza virological surveillance
During the 5-year study period, 15,883 specimens from outpatient clinic visits by persons with ILI were tested for influenza. There was a decline in the annual number of specimens tested from 6,971 in 2010 to 1,801 in 2013, and thereafter it increased to 2,096 in 2014. Overall, there were 7,411 positive results for influenza (46.7%). The annual proportion of influenza-positive results ranged from 40.7% to 49.6%. The weekly proportion of influenza-positive isolates across all ages is shown in Figure 1 .
Influenza-associated hospitalizations
The estimated annual all-ages influenza-associated hospitalization rates per 100,000 person-years ranged from 9.5 to 12.2 for IHD, 7.7 to 9.1 for CHF, and 15.8 to 19.2 for overall CVD. Multivariable negative binomial regression models identified significant associations between influenza and hospitalizations in the elderly ≥80 years of age for IHD (P = 0.02), CHF (P = 0.01), and overall CVD (P < 0.001) as well as in the all-ages group for CHF (P = 0.03) ( Table 2) . Estimated coefficients and standard errors of influenza positivity from the negative binomial regression models are presented in Web Table 1 (available at https://academic. oup.com/aje).
In elderly persons ≥80 years of age, the estimated influenza-associated excess hospitalization rate per 100,000 person-years was 242.7 (95% confidence interval (CI): 162.7, 337.1) for IHD, 271.8 (95% CI: 177.3, 398.9) for CHF, and 497.2 (95% CI: 348.9, 669.6) for overall CVD. The estimated influenza-associated excess hospitalization rate per 100,000 person-years was 8.3 (95% CI: 5.1, 12.4) for CHF in the all-ages group. For all 3 disease groups, the estimated influenza-associated excess hospitalization rates per 100,000 person-years increased with increasing age. See Table 3 .
The estimated annual influenza-associated proportions in the all-ages group ranged from 3.0% to 3.9% for IHD, 5.7% to 6.9% for CHF, and 3.2% to 3.8% for overall CVD. For IHD and overall CVD, the influenza-associated proportion of hospitalizations both followed a J-shaped pattern with the highest proportions among persons ≥80 years of age, followed by those in the youngest age group (<50 years of age) (Figure 2 ). For CHF, the influenza-associated proportion was highest, at 14.4%, among the youngest age group (aged <50 years), followed by 12.6% among those in the oldest age group (aged ≥80 years).
DISCUSSION
To our knowledge, this is the first study to provide a population-based estimate of influenza-associated hospitalizations for CVD. We found that influenza contributed a substantial burden of disease on hospitalizations for overall and specific CVD in the tropics, especially in the elderly.
A key assumption regarding the virological surveillance in Singapore is that influenza activity is adequately captured by the overall proportion of ILI specimens that have tested positive for influenza virus. This readily available laboratorybased measure serves as a useful indicator for timely monitoring, because the virological data originates from a nationwide community-based network of sentinel primary care clinics in both the public and private sectors (14) . The Ministry of Health's robust surveillance system for influenza included other indicators-such as government primary care clinic attendance as well as emergency department attendance and admissions in public acute-care hospitals for acute respiratory infections-which have generally correlated well with the overall proportion of ILI specimens that tested positive for influenza virus. Because the weekly attendance numbers for ILI in the community were not available, we were unable to multiply attendance by the overall proportion of ILI specimens that tested positive to estimate the weekly attendance rate due to influenza. Estimation of disease burden associated with influenza is feasible only when virological surveillance is well established (15) . In several studies in temperate countries (1, 16, 17) and cities in the subtropics and tropics (6, (11) (12) (13) where the virus-driven modeling approach is used, the proportion of respiratory specimens positive for influenza was used to reflect virus activity.
The association of influenza with respiratory-related hospitalizations has been shown in multiple studies (1, 11) . However, data on CVD hospitalizations have been variable and are especially lacking in the tropics. Tropical regions exhibit different influenza seasonal patterns compared with temperate regions. While there is a single annual epidemic during winter months in temperate countries, influenza spreads throughout the year in the tropics with bimodal peaks (10). A previous study in tropical Singapore, conducted in 2010-2012, reported the influenza-associated hospitalization rate per 100,000 person-years and proportion for pneumonia and influenza to be 29.6 (95% CI: 19.7, 40.6) and 11.2% (95% CI: 7.5, 15.4), respectively (11) . In comparison, we found an influenza-associated hospitalization rate per 100,000 person-years and proportion for overall CVD to be 17.8 (95% CI: 10.0, 29.1) and 3.6% (95% CI: 2.0, 5.9), respectively, during 2010-2014. Although the burden of influenza on CVD appears smaller than the burden of influenza on respiratory illnesses, the overall contribution is still important given the overall burden of CVD. CVD includes a large spread of disease subtypes, among which IHD and CHF hold great interest. With regard to IHD, a retrospective registry study of 20,000 patients in the (temperate) United Kingdom found that systemic respiratory infections significantly increased the risk of acute myocardial infarctions by approximately 5 times (18) . Another study in the United States found a significant association between influenza and the IHD mortality rate during winter (4). In our study, we found that the burden of influenza on IHD increased with age and was significantly associated with excess hospitalizations for IHD, predominantly in the elderly (≥80 years of age), who had an influenza-associated hospitalization rate of 242.7 (95% CI: 162.7, 337.1) per 100,000 person-years. This finding of increased influenzaassociated risk of IHD morbidity, particularly in the elderly, has been supported by several other studies. In subtropical Hong Kong, influenza was significantly associated with an (6) . In the United States, influenza was associated with acute myocardial infarctions mainly in persons aged ≥65 years (particularly in the age group of ≥80 years) and not in those aged <65 years of age (5) . For CHF, we found that influenza was significantly associated with excess hospitalizations in the all-ages group as well as in the elderly in the age group ≥80 years. A study in subtropical Hong Kong found influenza to be significantly associated with excess hospitalizations for CHF in the elderly (8) . In a cohort of CHF patients, there was increased mortality rate and hospitalizations during influenza seasons as compared with noninfluenza seasons (7). The influenzaassociated proportion for CHF hospitalizations for the allages group was 6.3% in our study. Interestingly, our study showed that the highest proportion of influenza-associated hospitalization for CHF was in the youngest age group (<50 years), followed by the oldest age group (≥80 years). While the role of influenza in the elderly has been well documented (8) , one possibility is that, in the young, other precipitants of heart failure (such as ischemia) may play a less significant role, and a larger proportion may be attributable to viral infections like influenza causing myocarditis. This unique finding raises important implications in the management of cardiac failure in the young. The pathophysiology of influenza resulting in CHF mortality and morbidity has been attributed to systemic inflammation. However, studies have also shown that influenza infection results in increased proinflammatory cytokines, which causes endothelial dysfunction, increased plasma viscosity, and release of endogenous catecholamines (19) . Clinically, this may result in tachycardia, hypoxemia, and increased metabolic requirements. Another hypothesis is that the direct invasion of the cells of the vessel wall might lead to an autoimmune response to these cells (20) .
Our study highlights the burden of influenza on CVD in the tropics. These national estimates of influenza-associated hospitalizations could aid in understanding the epidemiology of influenza over time and aid in resource planning in terms of health-care manpower needs during epidemics as well as influenza vaccinations in the tropics. The findings of this study support the use of the influenza vaccination among the elderly and those with CVD across all ages. This is consistent with the recommendations by the Singapore Expert Committee on Immunisation (11), the American Heart Association/American College of Cardiology guidelines (21, 22) , and the US Centers for Disease Control and Prevention (23) . Influenza vaccination serves as an important public health intervention. The Flu Vaccination Acute Coronary Syndromes (FLUVACS) study in patients presenting with acute coronary syndromes/IHD showed that influenza vaccination reduced the risk of death and ischemic events (24) . Other studies have also showed reduced hospitalizations for CHF with the use of influenza vaccination (25, 26) . In the elderly, influenza vaccination has been shown to reduce hospitalizations for cardiac disease (27) as well as cardiovascular deaths (28) . While influenza vaccination is a safe, inexpensive, and effective method to reduce morbidity in high-risk patients with CVD, it has been acknowledged that vaccination against influenza has been underutilized from a public health perspective. Globally, influenza vaccination coverage has shown modest improvements in recent years, but overall coverage remains low (29) . In Singapore, only 11.2% of adults reported having been vaccinated against influenza in the last 12 months (11). Our study has several limitations. First, there may be unmeasured factors that could affect the estimates of influenzaassociated hospitalizations despite our best efforts in controlling for potential confounding factors in the models. These factors might include the uptake of influenza vaccines in the population, seasonal variation in vaccine match to circulating influenza strains, and changes in health-seeking behavior (11). We did not adjust for the circulation of other respiratory viruses (other than respiratory syncytial virus), such as parainfluenza viruses, in the models for the estimation of influenzaassociated hospitalizations. Second, there could be variation in laboratory testing patterns over time and sentinel sites for the influenza virological surveillance. Because the specimens were collected from outpatients with ILI seen at government primary care clinics and private general practitioner clinics that were geographically spread out in Singapore, we assumed that the virological data were representative of influenza virus activity in the community. Third, the in-hospital influenza testing was based on clinical judgment, which may have preselected for patients at higher risk of influenza infection. Last, the change from ICD-9 to ICD-10 for hospitals (in 2012) may have affected the coding of cause-specific diagnosis; our analysis was confined to hospitalizations based on the principal discharge diagnosis of the 3 disease groupings.
In conclusion, in the tropics, influenza affects the cardiovascular health of the population and accounts for CVD-related hospitalizations, especially in the elderly. This provides evidence for public health strategies such as vaccinations, in particular focusing on the elderly, to minimize the burden of influenza.
